HBC Interim Director
Bill Picking stepped down from his position as director of the Higuchi Biosciences Center (HBC) at the end of June 2019 to focus on his research and teaching commitment. As of July 1st, John Stobaugh assumed the role of interim director of HBC. He is a professor of pharmaceutical chemistry and associate dean of research & graduate affairs in the School of Pharmacy. He also serves as associate director of academic research at the HBC.
We would like to take this opportunity to thank Bill Picking for his service as director of the HBC for these past five years.
O’Leary Shared Service Center Satellite Office
This is a reminder that on July 17, 2019 the O’Leary Shared Service Center began to hold office hours in KU’s West District to facilitate in-person meetings for PI’s located in the district. The satellite office is located in McCollum Laboratories, Room 129. It is open the 1st and 3rd Wednesday of the month from 1 to 4 pm.
Upcoming Fall Symposium
The An HBC sponsored symposium is scheduled for this coming fall. The 2019 Great Plains Regional Annual Symposium on Protein and Biomolecular NMR (GRASP NMR), a regional symposium on macromolecular NMR applications and techniques, will be held at the KU School of Pharmacy building on November 22 -23, 2019. Registration is currently open and early-bird registration fees will be available until September 10, 2019.
J.R. & Inez Jay Fund Research Awards
Two projects were selected this year to receive the 2019 J.R. and Inez Jay Fund research award at the University of Kansas. The first proposal selected, titled “Sugar coated vaccines for the treatment of opioid use disorder,” was submitted by Mark Farrell, assistant professor of medicinal chemistry, and Adam Smith, assistant professor of pharmacology and toxicology. The project will investigate a new approach to opioid conjugate vaccines.
The second project selected was submitted by Mark Richter, professor of molecular biosciences. The project, titled “Continuous monitoring of histamine in the brain,” will be conducted in collaboration with Candan Tamerler, professor of mechanical engineering, Paul Hanson, professor of chemistry, and George Wilson, distinguished professor emeritus of chemistry. The proposal addresses the need for real-time continuous measurement of histamine levels in the brain and in other tissues as a biomarker and pre-indicator of multiple immunological, neurological, and cardiovascular disorders.
KU NIH Center of Biomedical Research Excellence (CoBRE) in Chemical Biology of Infectious Disease (CBID) Pilot Projects awards
The KU NIH CoBRE in Chemical Biology of Infectious Disease (CBID) received sixteen innovative and well qualified Pilot Project applications in February. Out of the six selected proposals (four potential awards and two alternates) sent to NIH, four projects were approved. They are:
- Dr. Brian Ackley – University of Kansas, “On again, off again: Is pH a critical factor in pathogen killing?”
- Dr. Josie Chandler – University of Kansas, “Chemical biology studies of malleilactone, a small-molecule toxin produced by Burkholderia pseudomallei”
- Dr. Philip Hardwidge – Kansas State University, “Bacterial glycosyltransferase inhibitors as anti-virulence compounds”
- Dr. Wolfram Zückert – University of Kansas Medical Center, “Small molecule inhibitors of bacterial surface lipoprotein secretion”
Congratulations to all.